Table 3 Effect of peri-operative chemotherapy on survival for metachronous CRCLM
| Â | Number of patients | 3-year survival rate (%) | 5-year survival rate (%) | Univariate P-value |
|---|---|---|---|---|
Chemotherapy before hepatectomy | Â | Â | Â | Â |
Present | 32 | 53.2 | 45.6 | 0.1872 |
Absent | 23 | 80.0 | 72.8 | Â |
Chemotherapy after hepatectomy | Â | Â | Â | Â |
Present | 36 | 57.9 | 53.1 | 0.7919 |
Absent | 15 | 72.2 | 61.9 | Â |